Watchlist Manager

Watchlist

Price: 29 000 IDR

Market Cap: Rp104.4B

O	Organon Pharma Indonesia Tbk PT IDX:SCPI	ID

Income Statement

Currency: IDR

	Dec-2002	Mar-2003	Jun-2003	Sep-2003	Dec-2003	Mar-2004	Jun-2004	Sep-2004	Dec-2004	Mar-2005	Jun-2005	Sep-2005	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	97	91	86	89	0	85	88	86	0	8	7	10	0	2	3	(3)	103	0	101	123	138	0	0	0	127	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3 673	1 106	2 137	2 118	2 180	3 305	21 170	22 811	25 349	27 752	32 863	34 219	34 565	34 848	0	6 161	8 349	9 996	14 387	13 715	31 386	33 789	34 709	34 548	26 489	27 821	28 325	27 458	22 285	17 741	12 972	8 897	5 035	2 342	1 327	970	999	991	828	848	0	861	460	436	0	0
Revenue	109 925 N/A	120 916 +10%	114 586 -5%	117 255 +2%	117 435 +0%	106 334 -9%	110 152 +4%	108 738 -1%	112 005 +3%	114 041 +2%	116 069 +2%	124 559 +7%	132 729 +7%	138 005 +4%	137 247 -1%	142 601 +4%	123 758 -13%	127 789 +3%	140 622 +10%	143 908 +2%	170 351 +18%	179 243 +5%	187 784 +5%	195 396 +4%	204 012 +4%	221 823 +9%	250 990 +13%	272 685 +9%	284 900 +4%	286 624 +1%	274 044 -4%	257 222 -6%	260 316 +1%	257 151 -1%	274 321 +7%	296 827 +8%	273 311 -8%	277 796 +2%	260 906 -6%	267 185 +2%	302 830 +13%	308 432 +2%	362 524 +18%	271 034 -25%	347 835 +28%	691 170 +99%	965 818 +40%	1 238 045 +28%	1 594 052 +29%	2 002 968 +26%	2 260 572 +13%	2 405 168 +6%	2 503 626 +4%	2 393 004 -4%	1 216 250 -49%	1 155 975 -5%	2 184 624 +89%	2 235 996 +2%	2 091 158 -6%	2 040 652 -2%	2 205 542 +8%	1 908 631 -13%	1 927 804 +1%	2 020 658 +5%	1 841 268 -9%	2 176 822 +18%	2 358 638 +8%	2 546 446 +8%	2 893 298 +14%	2 567 275 -11%	2 431 798 -5%	2 367 959 -3%	2 159 191 -9%	2 222 570 +3%	2 367 004 +6%	2 287 479 -3%	2 339 388 +2%	2 484 466 +6%	2 747 530 +11%	1 200 136 -56%	1 857 740 +55%	2 762 266 +49%	2 895 902 +5%	3 089 374 +7%	3 279 031 +6%	3 548 718 +8%
Gross Profit
Cost of Revenue	(69 690)	(80 931)	(74 819)	(74 545)	(72 778)	(57 715)	(58 877)	(57 467)	(58 658)	(60 181)	(61 546)	(65 951)	(70 511)	(72 800)	(73 254)	(74 469)	(53 119)	(53 673)	(58 908)	(63 368)	(88 349)	(93 920)	(98 921)	(100 546)	(101 735)	(110 840)	(133 183)	(151 472)	(171 284)	(181 383)	(180 070)	(168 133)	(165 908)	(155 123)	(166 890)	(212 699)	(204 148)	(218 772)	(207 004)	(189 264)	(175 515)	(177 147)	(202 748)	(199 330)	(287 577)	(593 443)	(861 652)	(1 071 281)	(1 344 704)	(1 683 413)	(1 837 376)	(2 003 939)	(2 125 601)	(2 031 237)	(1 048 984)	(961 556)	(1 855 951)	(1 806 921)	(1 680 620)	(1 685 156)	(1 788 658)	(1 500 502)	(1 558 989)	(1 636 039)	(1 537 016)	(1 838 535)	(2 001 818)	(2 104 032)	(2 464 083)	(2 227 231)	(2 056 910)	(2 103 777)	(1 946 722)	(1 989 930)	(2 120 415)	(1 977 652)	(2 077 415)	(2 197 915)	(2 449 763)	(1 193 862)	(1 756 850)	(2 555 444)	(2 595 140)	(2 746 977)	(2 948 627)	(3 173 280)
Gross Profit	40 235 N/A	39 985 -1%	39 767 -1%	42 710 +7%	44 658 +5%	48 619 +9%	51 276 +5%	51 272 0%	53 347 +4%	53 861 +1%	54 522 +1%	58 607 +7%	62 218 +6%	65 204 +5%	63 993 -2%	68 132 +6%	70 638 +4%	74 116 +5%	81 714 +10%	80 540 -1%	82 002 +2%	85 323 +4%	88 863 +4%	94 849 +7%	102 277 +8%	110 982 +9%	117 806 +6%	121 213 +3%	113 616 -6%	105 241 -7%	93 974 -11%	89 089 -5%	94 408 +6%	102 028 +8%	107 431 +5%	84 128 -22%	69 163 -18%	59 025 -15%	53 903 -9%	77 922 +45%	127 315 +63%	131 286 +3%	159 777 +22%	71 704 -55%	60 258 -16%	97 727 +62%	104 166 +7%	166 764 +60%	249 348 +50%	319 555 +28%	423 196 +32%	401 229 -5%	378 025 -6%	361 767 -4%	167 266 -54%	194 418 +16%	328 673 +69%	429 075 +31%	410 537 -4%	355 496 -13%	416 884 +17%	408 128 -2%	368 816 -10%	384 619 +4%	304 252 -21%	338 287 +11%	356 819 +5%	442 414 +24%	429 215 -3%	340 043 -21%	374 888 +10%	264 182 -30%	212 470 -20%	232 640 +9%	246 589 +6%	309 828 +26%	261 973 -15%	286 552 +9%	297 766 +4%	6 274 -98%	100 890 +1 508%	206 822 +105%	300 763 +45%	342 397 +14%	330 403 -4%	375 438 +14%
Operating Income
Operating Expenses	(35 174)	(33 850)	(33 282)	(33 010)	(36 529)	(36 654)	(38 400)	(39 122)	(48 068)	(49 646)	(51 886)	(54 518)	(55 778)	(56 629)	(56 940)	(57 791)	(60 950)	(60 661)	(61 515)	(64 077)	(64 192)	(66 363)	(69 009)	(71 313)	(72 049)	(75 124)	(75 764)	(75 061)	(77 878)	(79 801)	(85 311)	(81 088)	(90 081)	(90 549)	(91 342)	(102 079)	(93 105)	(97 057)	(101 262)	(106 235)	(123 673)	(144 700)	(166 560)	(99 828)	(97 986)	(132 194)	(158 495)	(122 725)	(145 290)	(127 470)	(168 572)	(190 311)	(138 213)	(130 124)	(15 425)	(22 711)	(133 195)	(138 953)	(144 168)	(162 750)	(178 648)	(222 648)	(225 455)	(232 354)	(165 856)	(144 108)	(115 317)	(164 448)	(155 961)	(143 689)	(168 516)	(83 714)	(55 855)	(43 779)	(53 821)	(46 316)	(43 669)	(44 337)	(58 108)	(40 219)	(52 388)	(71 011)	(66 190)	(66 494)	(71 246)	(69 785)
Selling, General & Administrative	(35 174)	(33 849)	(33 282)	(33 011)	(36 529)	(36 410)	(37 938)	(38 448)	(48 068)	(48 713)	(50 554)	(52 796)	(55 778)	(54 776)	(55 702)	(57 155)	(60 950)	(60 660)	(61 515)	(64 076)	(64 192)	(66 361)	(69 008)	(71 313)	(72 049)	(75 126)	(75 765)	(75 063)	(77 878)	(79 802)	(85 311)	(81 087)	(90 081)	(90 548)	(91 341)	(102 078)	(93 105)	(97 056)	(101 262)	(106 235)	(123 673)	(144 701)	(166 561)	(99 829)	(97 987)	(132 194)	(155 896)	(121 623)	(142 324)	(124 506)	(165 414)	(185 838)	(134 949)	(126 284)	(14 850)	(22 711)	(133 195)	(138 955)	(144 169)	(162 751)	(178 648)	(222 647)	(225 455)	(232 354)	(165 856)	(144 108)	(115 317)	(164 448)	(155 961)	(143 689)	(168 516)	(83 714)	(55 855)	(43 779)	(53 821)	(46 316)	(43 669)	(44 337)	(56 169)	(39 675)	(51 301)	(69 379)	(63 927)	(64 196)	(68 913)	(67 440)
Depreciation & Amortization	0	0	0	0	0	(245)	(462)	(675)	0	(935)	(1 333)	(1 722)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1 102)	(2 966)	0	(3 158)	(4 475)	(3 266)	(3 841)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1 939)	(544)	(1 088)	(1 631)	(2 263)	(2 299)	(2 333)	(2 345)
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	(1 853)	(1 238)	(636)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(2 599)	0	0	(2 964)	0	0	0	0	(575)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	5 061 N/A	6 137 +21%	6 487 +6%	9 700 +50%	8 129 -16%	11 965 +47%	12 876 +8%	12 150 -6%	5 279 -57%	4 214 -20%	2 636 -37%	4 091 +55%	6 440 +57%	8 577 +33%	7 054 -18%	10 341 +47%	9 689 -6%	13 455 +39%	20 199 +50%	16 464 -18%	17 810 +8%	18 961 +6%	19 854 +5%	23 535 +19%	30 228 +28%	35 856 +19%	42 041 +17%	46 150 +10%	35 738 -23%	25 438 -29%	8 662 -66%	8 001 -8%	4 327 -46%	11 479 +165%	16 088 +40%	(17 952) N/A	(23 942) -33%	(38 032) -59%	(47 359) -25%	(28 313) +40%	3 642 N/A	(13 415) N/A	(6 783) +49%	(28 123) -315%	(37 728) -34%	(34 466) +9%	(54 329) -58%	44 040 N/A	104 060 +136%	192 086 +85%	254 624 +33%	210 918 -17%	239 811 +14%	231 642 -3%	151 841 -34%	171 707 +13%	195 477 +14%	290 120 +48%	266 368 -8%	192 745 -28%	238 236 +24%	185 480 -22%	143 361 -23%	152 265 +6%	138 396 -9%	194 179 +40%	241 502 +24%	277 966 +15%	273 254 -2%	196 354 -28%	206 372 +5%	180 468 -13%	156 615 -13%	188 861 +21%	192 768 +2%	263 511 +37%	218 304 -17%	242 215 +11%	239 658 -1%	(33 944) N/A	48 502 N/A	135 811 +180%	234 572 +73%	275 903 +18%	259 157 -6%	305 654 +18%
Pre-Tax Income
Interest Income Expense	(5 077)	(2 447)	(4 972)	(4 551)	(3 964)	(3 842)	(5 846)	(4 840)	(5 040)	(4 934)	(4 630)	(5 689)	(6 396)	(6 992)	(8 409)	(10 325)	(10 584)	(11 463)	(11 693)	(11 001)	(11 697)	(11 863)	(11 875)	(11 854)	(17 785)	(21 978)	(22 803)	(23 827)	(19 121)	(16 051)	(15 585)	(15 942)	(15 953)	(16 177)	(16 433)	(17 968)	(16 448)	(15 702)	(22 616)	(22 278)	(24 112)	(18 822)	(22 382)	15 719	4 253	2 876	(47 263)	(116 149)	(120 901)	(225 906)	(102 792)	(40 684)	(2 175)	111 334	14 816	3 728	(5 730)	(13 994)	(45 276)	(97 725)	(80 767)	(48 219)	(30 713)	15 069	1 614	(21 561)	(21 894)	(17 736)	(25 780)	(25 226)	(20 123)	(14 336)	(4 761)	(2 232)	(247)	1 998	1 332	(1 538)	(5 098)	(1 095)	(2 332)	(3 104)	(3 452)	(2 290)	(2 411)	(3 156)
Gain/Loss on Disposition of Assets	17	25	83	41	1 463	1 353	2 571	2 584	1 589	1 585	381	422	982	1 161	1 139	1 266	436	390	375	252	881	1 723	1 699	1 568	1 348	727	795	1 049	1 266	1 514	1 578	1 070	619	665	1 610	1 774	1 974	1 302	681	1 110	324	1 136	645	(5)	(12)	28	0	0	8	0	(1 263)	(1 092)	(1 101)	(1 101)	106	106	(697)	(734)	(840)	(840)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income	(460)	(4 229)	(5 309)	(5 403)	(324)	(2 117)	(6 424)	(6 481)	(227)	1 744	1 603	1 383	(122)	(534)	(571)	216	(229)	(422)	(181)	(1 107)	(694)	(89)	(344)	205	(509)	(623)	(243)	(528)	360	38	(462)	(431)	3 514	5 321	8 609	10 219	10 237	11 642	16 997	18 281	8 360	9 685	3 572	7 622	14 140	22 845	30 832	33 177	30 429	20 144	47 801	43 200	36 183	38 897	(9 883)	(14 010)	(8 408)	(8 014)	25 752	27 284	35 635	35 152	25 864	38 146	41 977	40 189	38 785	38 323	41 212	34 572	21 576	2 581	14 250	5 130	580	26 434	7 912	13 349	4 836	5 426	7 365	10 351	10 550	12 013	12 507	15 790
Pre-Tax Income	(460) N/A	(512) -11%	(3 709) -624%	(211) +94%	5 303 N/A	7 361 +39%	3 179 -57%	3 414 +7%	1 601 -53%	2 608 +63%	(11) N/A	206 N/A	903 +338%	2 212 +145%	(787) N/A	1 499 N/A	(689) N/A	1 962 N/A	8 700 +343%	4 608 -47%	6 301 +37%	8 732 +39%	9 336 +7%	13 456 +44%	13 282 -1%	13 982 +5%	19 790 +42%	22 846 +15%	18 242 -20%	10 940 -40%	(5 807) N/A	(7 302) -26%	(7 493) -3%	1 288 N/A	9 875 +667%	(23 926) N/A	(28 180) -18%	(40 791) -45%	(52 297) -28%	(31 201) +40%	(11 786) +62%	(21 414) -82%	(24 947) -16%	(4 788) +81%	(19 348) -304%	(8 718) +55%	(70 760) -712%	(38 930) +45%	13 598 N/A	(13 676) N/A	198 370 N/A	212 343 +7%	272 720 +28%	380 772 +40%	156 881 -59%	161 532 +3%	180 642 +12%	267 380 +48%	246 005 -8%	121 464 -51%	193 104 +59%	172 413 -11%	138 511 -20%	205 479 +48%	181 987 -11%	212 808 +17%	258 392 +21%	298 553 +16%	288 685 -3%	205 700 -29%	207 826 +1%	168 713 -19%	166 104 -2%	191 759 +15%	193 101 +1%	291 944 +51%	227 549 -22%	254 026 +12%	239 396 -6%	(29 614) N/A	53 534 N/A	143 058 +167%	241 671 +69%	285 626 +18%	269 253 -6%	318 288 +18%
Net Income
Tax Provision	(588)	(588)	(2 238)	(2 430)	(2 910)	(2 910)	(2 453)	(2 658)	(1 933)	(1 934)	(1 524)	(1 637)	(1 767)	(1 767)	(472)	38	(1 804)	(4 138)	(5 497)	(5 451)	(3 732)	(4 289)	(4 218)	(5 807)	(6 662)	(6 812)	(8 138)	(8 867)	(7 453)	(5 722)	(1 721)	487	(550)	(2 085)	(4 912)	1 817	2 759	5 572	8 705	3 001	(581)	(93)	2 698	3 215	(1 269)	(1 269)	8 298	(11 108)	(12 413)	(12 206)	(59 049)	(53 364)	(72 239)	(95 443)	(39 704)	(41 780)	(58 127)	(79 380)	(73 697)	(41 502)	(66 012)	(62 264)	(53 361)	(74 771)	(69 335)	(78 609)	(90 749)	(90 451)	(70 322)	(46 111)	(45 028)	(41 621)	(47 412)	(44 528)	(42 249)	(74 297)	(52 766)	(61 743)	(51 694)	3 312	(15 742)	(36 898)	(55 055)	(65 270)	(62 554)	(73 664)
Income from Continuing Operations	(1 048)	(1 100)	(5 947)	(2 641)	2 393	4 451	726	757	(332)	675	(1 534)	(1 431)	(864)	445	(1 259)	1 537	(2 493)	(2 176)	3 203	(844)	2 569	4 441	5 116	7 648	6 621	7 170	11 652	13 979	10 789	5 218	(7 528)	(6 815)	(8 043)	(797)	4 964	(22 107)	(25 420)	(35 218)	(43 592)	(28 201)	(12 367)	(21 507)	(22 249)	(1 573)	(20 617)	(9 987)	(62 461)	(50 038)	1 185	(25 882)	139 322	158 980	200 481	285 328	117 176	119 752	122 515	188 000	172 309	79 963	127 092	110 150	85 150	130 709	112 653	134 198	167 644	208 102	218 363	159 589	162 798	127 092	118 692	147 230	150 852	217 646	174 782	192 283	187 702	(26 302)	37 793	106 160	186 616	220 356	206 700	244 624
Net Income (Common)	(1 048) N/A	(1 100) -5%	(5 947) -441%	(2 641) +56%	2 393 N/A	4 451 +86%	726 -84%	757 +4%	(332) N/A	675 N/A	(1 534) N/A	(1 431) +7%	(864) +40%	445 N/A	(1 259) N/A	1 537 N/A	(2 493) N/A	(2 176) +13%	3 203 N/A	(844) N/A	2 569 N/A	4 441 +73%	5 116 +15%	7 648 +49%	6 621 -13%	7 170 +8%	11 652 +63%	13 979 +20%	10 789 -23%	5 218 -52%	(7 528) N/A	(6 815) +9%	(8 043) -18%	(797) +90%	4 964 N/A	(22 107) N/A	(25 420) -15%	(35 218) -39%	(43 592) -24%	(28 201) +35%	(12 367) +56%	(21 507) -74%	(22 249) -3%	(1 573) +93%	(20 617) -1 211%	(9 987) +52%	(62 461) -525%	(50 038) +20%	1 185 N/A	(25 882) N/A	139 322 N/A	158 980 +14%	200 481 +26%	285 328 +42%	117 176 -59%	119 752 +2%	122 515 +2%	188 000 +53%	172 309 -8%	79 963 -54%	127 092 +59%	110 150 -13%	85 150 -23%	130 709 +54%	112 653 -14%	134 198 +19%	167 644 +25%	208 102 +24%	218 363 +5%	159 589 -27%	162 798 +2%	127 092 -22%	118 692 -7%	147 230 +24%	150 852 +2%	217 646 +44%	174 782 -20%	192 283 +10%	187 702 -2%	(26 302) N/A	37 793 N/A	106 160 +181%	186 616 +76%	220 356 +18%	206 700 -6%	244 624 +18%
EPS (Diluted)	-262 N/A	-275 -5%	-1 486.75 -441%	-660.25 +56%	598.25 N/A	1 112.75 +86%	181.5 -84%	189.25 +4%	-83 N/A	168.75 N/A	-383.5 N/A	-357.75 +7%	-216 +40%	111.25 N/A	-314.75 N/A	384.25 N/A	-623.25 N/A	-544 +13%	800.75 N/A	-211 N/A	642.25 N/A	1 110.25 +73%	1 279 +15%	1 912 +49%	1 655.25 -13%	1 792.5 +8%	2 913 +63%	3 494.75 +20%	2 697.25 -23%	1 304.5 -52%	-1 882 N/A	-1 703.75 +9%	-2 010.75 -18%	-199.25 +90%	1 241 N/A	-5 526.75 N/A	-6 355 -15%	-8 804.5 -39%	-10 898 -24%	-7 050.25 +35%	-3 091.75 +56%	-5 376.75 -74%	-5 562.25 -3%	-393.25 +93%	-5 154.25 -1 211%	-2 496.75 +52%	-17 350.39 -595%	-12 509.5 +28%	296.25 N/A	-6 470.5 N/A	38 700.47 N/A	39 745 +3%	50 120.25 +26%	71 332 +42%	29 294 -59%	29 938 +2%	34 032.04 +14%	47 000 +38%	43 077.25 -8%	22 212.42 -48%	35 303.03 +59%	30 597.59 -13%	23 653.08 -23%	36 308.43 +54%	31 292 -14%	37 277.64 +19%	46 567.15 +25%	57 805.01 +24%	60 656 +5%	44 331.96 -27%	45 218.34 +2%	35 303.08 -22%	32 969.97 -7%	40 896.99 +24%	41 904.41 +2%	60 457.39 +44%	48 551 -20%	53 413.06 +10%	52 139.39 -2%	-7 306.16 N/A	10 497.92 N/A	29 488.83 +181%	51 837.67 +76%	61 209.89 +18%	57 416.56 -6%	67 951.15 +18%

Income Statement Balance Sheet Cash Flow Statement

Organon Pharma Indonesia Tbk PT
IDX:SCPI

Income Statement

Earnings Waterfall
Organon Pharma Indonesia Tbk PT

Income Statement
Organon Pharma Indonesia Tbk PT

See Also

Company

Help

Tools

Stocks

Organon Pharma Indonesia Tbk PT IDX:SCPI

Income Statement

Earnings Waterfall Organon Pharma Indonesia Tbk PT

Income Statement Organon Pharma Indonesia Tbk PT

See Also

Company

Help

Tools

Stocks

Organon Pharma Indonesia Tbk PT
IDX:SCPI

Earnings Waterfall
Organon Pharma Indonesia Tbk PT

Income Statement
Organon Pharma Indonesia Tbk PT